Precise gaussian distribution functions of maternal serum α-fetoprotein and free β-subunit of human chorionic gonadotropin for trisomy 21 screening: Improved accuracy for patient counseling

American Journal of Obstetrics and Gynecology

Volumn 177, Issue 4, 1997, Pages 882-886

  Chik, L ^a   Spencer, K ^a   Johnson, M P ^a   Ayoub, M ^a   Krivchenia, E L ^a   Dombrowski, M P ^a   Sokol, R J ^a   Evans, M I ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gaussian distribution; Human chorionic gonadotropin; Trisomy 21 screening; Fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ARTICLE; BLOOD ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FETUS; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PATIENT COUNSELING; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCREENING TEST; TRISOMY 21;

EID: 0030696655     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(97)70288-6     Document Type: Article

References (13)

1. MI Evans E Dvorin JE O'Brien JL Moody A Drugan Alpha-fetoprotein and biochemical screening MI Evans Reproductive risks and prenatal diagnosis 1992 Appleton & Lange Norwalk (CT) 223 227
2. A Reichler RF Hume Jr A Drugan M Bardicef NB Isada MP Johnson Risk of anomalies as a function of level of elevated maternal serum α-fetoprotein Am J Obstet Gynecol 171 1994 1052 1055
3. B Crandall L Robinson P Grau Risks associated with an elevated maternal serum α-fetoprotein level Am J Obstet Gynecol 165 1991 581 586
4. SF Goodburn JRW Yates PR Raggatt C Carr ME Ferguson-Smith AJ Kershaw Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme Prenat Diagn 14 1994 391 402
5. EY Cheng DA Luthy AM Zebelman MA Williams RE Lieppman DE Hickok A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol Obstet Gynecol 81 1993 72 77
6. MI Evans L Chik JE O'Brien B Chen E Dvorin M Ayoub MOMs and DADs: improved specificity and cost effectiveness of biochemical screening for aneuploidy with DADs Am J Obstet Gynecol 172 1995 1138 1147
7. MI Evans L Chik JE O'Brien E Dvorin MP Johnson E Krivchenia Logistic regression generated probability estimates for trisomy 21 outcomes from serum AFP and bHCG: simplification with increased specificity J Matern Fetal Med 5 1996 1 6
8. MI Evans RF Hume MP Johnson MC Treadwell E Krivchenia IE Zador Integration of genetics and ultrasound in prenatal diagnosis: just looking is not enough Am J Obstet Gynecol 174 1996 1926 1930
9. NJ Wald HS Cuckle JW Densem K Nanchalal P Royston J Chard Maternal serum screening for Down syndrome in early pregnancy BMJ 297 1988 883 888
10. ML MacDonald RM Wagner RN Slotnick Sensitivity and specificity of screening for Down syndrome with alpha- fetoprotein, hCG, unconjugated estriol, and maternal age Obstet Gynecol 77 1991 63 66
11. JA Canick GJ Knight GE Palomaki JE Haddow HS Cuckle NJ Wald Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome Br J Obstet Gynaecol 95 1988 330 335
12. JA Crossley DA Aitken JM Connor Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age Prenat Diagn 11 1991 83 101
13. A Drugan A Reichler M Bronstein MP Johnson RJ Sokol MI Evans Abnormal biochemical serum screening versus second trimester ultrasound-detected minor anomalies as predictors of aneuploidy in low risk patients Fetal Diagn Ther 11 1996 301 305